Home / Journals / Journal of Clinical Cardiology and Cardiovasular Diagnosis / Articles In Press

Mini Review

When Hormones Falter: Unraveling the Cardiovascular Consequences of Adrenal Insufficiency

Authors: Gillinov H11 Dahdah E11 Hamid T11 Schuler F11 Asirvatham S11 Madadlou W11

*Corresponding Author: Asirvatham S, Institute of Cardiology, Lithuanian University of Health Science, Lithuania

Copyright: © 2026 Asirvatham S, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Citation: Asirvatham S (2026) When Hormones Falter: Unraveling the Cardiovascular Consequences of Adrenal Insufficiency V1(3).

Received: Jan 19, 2026

Accepted: Feb 02, 2026

Published: Feb 10, 2026

Keywords: hormone replacement therapy, chronic inflammation, impaired vascular tone, impaired vasoconstriction, cardiac output, cardiovascular instability, adrenal crisis, cortisol rhythms

Abstract

Adrenal insufficiency (AI) is a potentially life-threatening endocrine disorder characterized by inadequate production of glucocorticoids, with or without mineralocorticoid deficiency. While its metabolic and immunological implications are well recognized, emerging evidence highlights a significant association between adrenal insufficiency and adverse cardiovascular outcomes. Patients with AI exhibit increased risks of hypotension, arrhythmias, endothelial dysfunction, and premature cardiovascular morbidity and mortality. These risks arise from complex interactions involving cortisol deficiency, impaired vascular tone, electrolyte imbalances, chronic inflammation, and suboptimal hormone replacement therapy. This article explores the pathophysiological mechanisms linking adrenal insufficiency to cardiovascular disease, reviews current clinical evidence, and discusses strategies for optimizing cardiovascular outcomes in affected individuals. Improved recognition and targeted management may reduce the cardiovascular burden associated with this often-underdiagnosed condition.

Introduction

Adrenal insufficiency is a disorder resulting from inadequate secretion of adrenal hormones, primarily cortisol, and in some cases aldosterone. It is broadly classified into primary (Addison’s disease), secondary, and tertiary forms based on the level of dysfunction within the hypothalamic–pituitary–adrenal (HPA) axis. Although traditionally associated with symptoms such as fatigue, weight loss, and hyperpigmentation, the cardiovascular implications of AI are increasingly gaining attention.

The cardiovascular system is highly sensitive to hormonal regulation, particularly glucocorticoids and mineralocorticoids. Their deficiency disrupts hemodynamic stability and contributes to both acute and chronic cardiovascular complications.

Pathophysiology Linking Adrenal Insufficiency and Cardiovascular Outcomes

1. Cortisol Deficiency and Vascular Tone

Cortisol plays a crucial role in maintaining vascular responsiveness to catecholamines. In adrenal insufficiency, reduced cortisol levels lead to decreased vascular tone and impaired vasoconstriction, resulting in hypotension and, in severe cases, shock.

2. Aldosterone Deficiency and Electrolyte Imbalance

In primary adrenal insufficiency, aldosterone deficiency leads to:

  • Hyponatremia

  • Hyperkalemia

  • Reduced intravascular volume

These changes can cause arrhythmias, decreased cardiac output, and increased cardiovascular instability.

3. Endothelial Dysfunction and Inflammation

Chronic cortisol deficiency may promote low-grade inflammation and endothelial dysfunction, both of which are critical contributors to atherosclerosis and cardiovascular disease.

4. Impact of Hormone Replacement Therapy

Glucocorticoid replacement, while life-saving, may not perfectly mimic physiological cortisol rhythms. Over-replacement can lead to:

  • Hypertension

  • Dyslipidemia

  • Insulin resistance

Under-replacement, on the other hand, increases the risk of adrenal crisis and hypotension.

Clinical Cardiovascular Manifestations

Patients with adrenal insufficiency may present with a range of cardiovascular abnormalities, including:

  • Persistent low blood pressure

  • Orthostatic hypotension

  • Reduced exercise tolerance

  • Cardiac arrhythmias (due to electrolyte imbalance)

  • Increased risk of cardiovascular mortality

Adrenal crisis represents the most severe acute manifestation, often accompanied by circulatory collapse and requiring emergency intervention.

Evidence from Clinical Studies

Recent observational studies have demonstrated that individuals with adrenal insufficiency have higher rates of cardiovascular morbidity and mortality compared to the general population. Factors contributing to this increased risk include:

  • Delayed diagnosis

  • Recurrent adrenal crises

  • Inadequate hormone replacement

  • Coexisting autoimmune diseases

Additionally, patients with primary adrenal insufficiency often exhibit a higher prevalence of metabolic disturbances that further elevate cardiovascular risk.

Management Strategies to Improve Cardiovascular Outcomes

1. Optimized Hormone Replacement

  • Use of physiological dosing schedules

  • Modified-release glucocorticoids to mimic circadian rhythm

  • Careful titration to avoid over- or under-replacement

2. Monitoring Cardiovascular Risk Factors

  • Regular blood pressure assessment

  • Lipid profile monitoring

  • Screening for glucose intolerance

3. Patient Education

  • Recognition of adrenal crisis symptoms

  • Stress-dose steroid use during illness

  • Adherence to medication

4. Electrolyte Management

  • Monitoring sodium and potassium levels

  • Mineralocorticoid replacement when indicated

Future Directions

Advances in personalized medicine and hormone delivery systems may improve outcomes for patients with adrenal insufficiency. Research into biomarkers for optimal dosing and the development of more physiological hormone replacement therapies holds promise for reducing cardiovascular complications.

Conclusion
Adrenal insufficiency is more than an endocrine disorder—it has significant cardiovascular implications that can impact morbidity and mortality. Understanding the interplay between hormonal deficiency and cardiovascular function is essential for comprehensive patient care. Early diagnosis, individualized treatment, and vigilant monitoring are key to improving long-term outcomes and reducing cardiovascular risk in this vulnerable population.

References

  1. Téblick, A.; Peeters, B.; Langouche, L.; Van Den Berghe, G. Adrenal Function and Dysfunction in Critically Ill Patients. Nat. Rev. Endocrinol. 2019, 15, 417–427.
  2. Bornstein, S.R.; Allolio, B.; Arlt, W.; Barthel, A.; Don-Wauchope, A.; Hammer, G.D.; Husebye, E.S.; Merke, D.P.; Murad, M.H.; Stratakis, C.A.; et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. Lancet Diabetes Endocrinol. 2016, 4, 421–430.
  3. Hahn, R.T.; Makkar, R.; Thourani, V.H.; Makar, M.; Sharma, R.P.; Haeffele, C.; Davidson, C.J.; Narang, A.; O’neill, B.; Lee, J.; et al. Transcatheter Valve Replacement in Severe Tricuspid Regurgitation. N. Engl. J. Med. 2025, 392, 115–126.
  4. Van Der Linde, D.; Roos-Hesselink, J.W.; Rizopoulos, D.; Heuvelman, H.J.; Budts, W.; Van Dijk, A.P.J.; Witsenburg, M.; Yap, S.C.; Oxenius, A.; Silversides, C.K.; et al. Surgical Outcome of Discrete Subaortic Stenosis in Adults: A Multicenter Study. Circulation 2013, 127, 1184–1191.
  5. Shinn, S.H.; Schaff, H.V. Evidence-based surgical management of acquired tricuspid valve disease. Nat. Rev. Cardiol. 2013, 10, 190–203.
  6. Wichmann, D.; Sperhake, J.P.; Lütgehetmann, M.; Steurer, S.; Edler, C.; Heinemann, A.; Heinrich, F.; Mushumba, H.; Kniep, I.; Schröder, A.S.; et al. Autopsy Findings and Venous Thromboembolism in Patients with COVID-19. Ann. Intern. Med. 2020, 173, 268–277.
  7. Tudoran, C.; Tudoran, M.; Abu-Awwad, A.; Cut, T.G.; Voiță-Mekereș, F. Spontaneous Hematomas and Deep Vein Thrombosis during the Recovery from a SARS-CoV-2 Infection: Case Report and Literature Review. Medicina 2022, 58, 230.
  8. Jokinen, J.J.; Turpeinen, A.K.; Pitkänen, O.; Hippeläinen, M.J.; Hartikainen, J.E. Pacemaker therapy after tricuspid valve operations: Implications on mortality, morbidity, and quality of life. Ann. Thorac. Surg. 2009, 87, 1806–1814.